Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
According to Quantum-Si incorporated's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.96. At the end of 2022 the company had a P/E ratio of -1.81.
Year | P/E ratio |
---|---|
2023 | -2.96 |
2022 | -1.81 |
2021 | -7.04 |
2020 | -1.49 |
2019 | -37.65 |